Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature

doi:10.4254/wjh.v7.i12.1718

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6781)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

333

WORD

233

HTML

2404

Figures (1-1)

116

Tables (1-1)

160

Sum=3246

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

447

Download

854

Sum=1301

Publishing Process of This Article

Item

Count

Browse

876

Download

1358

Sum=2234

Jun 28, 2015 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Hepatol. Jun 28, 2015; 7(12): 1718-1722
Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1718

Open in New Tab Full Size Figure Download Figure

Figure 1 Total platelet count during antiviral treatment, after discontinuation and during steroid therapy. IFN: Interferon; Peg-IFN: Pegylated-IFN; RBV: Ribavirin.

Citation: Arena R, Cecinato P, Lisotti A, Buonfiglioli F, Calvanese C, Grande G, Montagnani M, Azzaroli F, Mazzella G. Severe immune thrombocytopenia after peg-interferon-alpha2a, ribavirin and telaprevir treatment completion: A case report and systematic review of literature. World J Hepatol 2015; 7(12): 1718-1722
URL: https://www.wjgnet.com/1948-5182/full/v7/i12/1718.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i12.1718